Proof of Usefulness Report

Sencilia

Analysis completed on 2/13/2026

+63

Proof of Usefulness Score

You're In Business

Sencilia is a verified DeepTech spin-off from the University of Groningen developing 'Rely-V' IV infusion flow sensors. The project demonstrates high real-world utility and technical innovation (MEMS/nanotech) with confirmed grant funding (~€800k) and pre-clinical pilots. However, the submission quality is critically low, containing significant errors (Project Name mismatch 'FrostShade', false claims of 'everyone' reach and 'most people' traction). The score reflects the strong underlying technology and problem-solution fit, heavily discounted by the inaccurate submission data and lack of commercial market entry.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+22.5

Audience Reach Impact+4

Technical Innovation+13.5

Evidence Of Traction+6.25

Market Timing Relevance+8

Functional Completeness+0.5

Subtotal+54.75

Usefulness Multiplierx1.15

Final Score+63

Project Details

Project URL

sencilia.nl

Description

Sencilia is an early-stage DeepTech/MedTech startup (spin off from the University of Groningen) with a mission to improve the safety and reliability of IV infusion therapy. We develop innovative sensor technology that is designed to enhance patient safety in neonatal, pediatric and adult intensive care by reducing the risk of IV infusion-related adverse drug events. Contact us to know more!

Algorithm Insights

Market Position

Growing utility with room for optimization

User Engagement

Documented reach suggests active user community

Technical Stack

Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline